PEARSE DIANE M
Known title: DirectorCIK: 0001283417
Associated companies
Transaction History
| MSA | ▲ Buy | Grant | 20 | $0 | 9/10/2026 | View on chart |
| MSA | ▲ Buy | Grant | 23 | $0 | 6/10/2026 | View on chart |
| MSA | ▲ Buy | Grant | 899 | $0 | 5/13/2026 | View on chart |
| MSA | ▲ Buy | Grant | 17 | $0 | 3/10/2026 | View on chart |
| MSA | ▲ Buy | Grant | 20 | $0 | 12/10/2025 | View on chart |
| MSA | ▲ Buy | Grant | 18 | $0 | 9/10/2025 | View on chart |
| MSA | ▲ Buy | Grant | 16 | $0 | 6/10/2025 | View on chart |
| MSA | ▲ Buy | Grant | 909 | $0 | 5/16/2025 | View on chart |
| MSA | ▲ Buy | Grant | 16 | $0 | 3/8/2025 | View on chart |
| MSA | ▲ Buy | Grant | 14 | $0 | 12/10/2024 | View on chart |
| MSA | ▲ Buy | Grant | 14 | $0 | 9/10/2024 | View on chart |
| MSA | ▲ Buy | Grant | 15 | $0 | 6/10/2024 | View on chart |
| MSA | ▲ Buy | Grant | 755 | $0 | 5/15/2024 | View on chart |
| MSA | ▲ Buy | Grant | 10 | $0 | 3/10/2024 | View on chart |
| MSA | ▲ Buy | Grant | 11 | $0 | 12/10/2023 | View on chart |
| MSA | ▲ Buy | Grant | 11 | $0 | 9/10/2023 | View on chart |
| MSA | ▲ Buy | Grant | 10 | $0 | 6/10/2023 | View on chart |
| MSA | ▲ Buy | Grant | 939 | $0 | 5/17/2023 | View on chart |
| MSA | ▼ Sell | Tax Withholding | 805 | $109K | 5/10/2023 | View on chart |
| MSA | ▲ Buy | Option Exercise | 2,179 | $109K | 5/10/2023 | View on chart |
| MSA | ▲ Buy | Grant | 11 | $0 | 3/10/2023 | View on chart |
| MSA | ▲ Buy | Grant | 11 | $0 | 12/10/2022 | View on chart |
| MSA | ▲ Buy | Grant | 12 | $0 | 9/10/2022 | View on chart |
| MSA | ▲ Buy | Grant | 7 | $0 | 6/10/2022 | View on chart |
| MSA | ▲ Buy | Grant | 1,129 | $0 | 5/18/2022 | View on chart |
| MSA | ▲ Buy | Option Exercise | 2,675 | $114K | 5/6/2022 | View on chart |
| MSA | ▼ Sell | Tax Withholding | 931 | $114K | 5/6/2022 | View on chart |
| MSA | ▲ Buy | Grant | 6 | $0 | 3/10/2022 | View on chart |
| MSA | ▲ Buy | Grant | 6 | $0 | 12/10/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 7, 2026
MSA Safety Upgraded Amid New SCBA Launch
MSA Safety received a Buy upgrade from analysts, who suggest the stock may be undervalued following the launch of a new connected Self-Contained Breathing Apparatus. This product development is seen as a key factor in the company's long-term growth potential. The stock currently trades below the average analyst price target, reflecting a valuation gap that some market participants are watching closely.
MSA Safety Upgraded Amid New SCBA Launch. MSA Safety received a Buy upgrade from analysts, who suggest the stock may be undervalued following the launch of a new connected Self-Contained Breathing Apparatus. This product development is seen as a key factor in the company's long-term growth potential. The stock currently trades below the average analyst price target, reflecting a valuation gap that some market participants are watching closely.